OptimizeRx Corp (OPRX) › Cost of RevenueOptimizeRx Corp (OPRX) — Cost of RevenueAnnual figures by period end, from SEC filings.2018-12-31: $9.00M2019-12-31: $9.16M2020-12-31: $19.21M2021-12-31: $25.65M2022-12-31: $23.48M2023-12-31: $28.62M2024-12-31: $32.75M2025-12-31: $35.83M$35.83M2018-12-31Cost of Revenue (USD)2025-12-31Period endedCost of RevenueChange YoYSource filing2025-12-31$35.83M+9.4%2026-03-12From 2025-01-012024-12-31$32.75M+14.4%2026-03-12From 2024-01-012023-12-31$28.62M+21.9%2025-03-20From 2023-01-012022-12-31$23.48M-8.5%2024-04-15From 2022-01-012021-12-31$25.65M+33.6%2023-03-10From 2021-01-012020-12-31$19.21M+109.7%2023-03-10From 2020-01-012019-12-31$9.16M+1.8%2021-03-08From 2019-01-012018-12-31$9.00M—2020-03-26From 2018-01-01Other metrics: RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)